PCN93 Cost-Effectiveness Analysis of DEB-TACE Compared to Lipiodol-TACE As First LINE Treatment for Unresectable HCC
Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.230
https://www.valueinhealthjournal.com/article/S1098-3015(20)32486-4/fulltext
Title :
PCN93 Cost-Effectiveness Analysis of DEB-TACE Compared to Lipiodol-TACE As First LINE Treatment for Unresectable HCC
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32486-4&doi=10.1016/j.jval.2020.08.230
First page :
Section Title :
Open access? :
No
Section Order :
10179